ElastiK° Skin | Skin in Evolution™
THE WEGOVY PILL AND YOUR SKIN: DOES A TABLET CHANGE ANYTHING?
By Marc McKee, Founder of ElastiK° Skin
TL;DR: THE ESSENTIAL POINTS
- The Wegovy pill was approved in the UK on 11 June 2026. It is oral semaglutide, the same medicine as the weekly Wegovy injection, taken as a daily tablet.1,2
- There is no skin-specific research on the tablet. No study has compared skin changes on the pill with the injection. Reviews say large studies of GLP-1 medicines and skin are still missing.5
- Most skin changes seem to come from the weight loss, not the delivery method. Facial hollowing and looser skin are described as effects of rapid weight loss.5,6
- One thing does change: no injections. Injection-site reactions such as redness, swelling and lumps are a known issue with injected GLP-1 medicines.5
- The safety advice is the same. Get it on prescription from a legitimate pharmacy, and seek urgent help for sudden changes in eyesight.3,4
"If I switch to the tablet, will it be easier on my skin?"
Since the Wegovy pill was approved, that question has come up again and again in our community. It is a reasonable thing to wonder. A different form of a medicine can mean different side effects.
The answer is less exciting than people hope, but it is useful. The tablet contains the same active medicine as the injection. What matters most for your skin is still how much weight you lose and how quickly, and how well you look after your skin along the way.
The honest headline.
There is no research looking specifically at skin on the Wegovy tablet. Anyone telling you the pill is gentler on skin, or harsher, is guessing.
This article covers what was approved, what is the same and what is different, what we know and do not know about skin, and how to look after your skin whichever form you take.
01. WHAT WAS APPROVED
On 11 June 2026, the Medicines and Healthcare products Regulatory Agency (MHRA) authorised Novo Nordisk's Wegovy (semaglutide) tablet, the first oral GLP-1 medicine for weight management in the UK.1,2
- Who it is for: adults with a BMI of 30 or above, or 27 to 30 with at least one weight-related health condition, alongside a reduced-calorie diet and more physical activity.1,2
- How the dose builds: starting at 1.5mg once a day, then 4mg, 9mg and 25mg, with at least a month at each step. People already on the 2.4mg weekly injection privately can move straight to 25mg tablets.1
- How it is taken: whole, on an empty stomach after fasting for at least eight hours, with a sip of water, then no food or drink for at least 30 minutes.1
- NHS availability: at approval it was not yet available on the NHS, as NICE needed to assess it first.2 Ask your GP or prescriber about the current position.
Oral semaglutide itself is not new. The first oral form was approved in 2019,5 and a semaglutide tablet, Rybelsus, was already on the MHRA's list of GLP-1 medicines before the Wegovy tablet arrived.3 What is new is a tablet licensed for weight management.2
02. PILL VS INJECTION: WHAT IS THE SAME, WHAT IS DIFFERENT
| Wegovy injection | Wegovy tablet | |
|---|---|---|
| Active medicine | Semaglutide1 | Semaglutide1 |
| How often | Once a week1 | Once a day1 |
| Top dose | 2.4mg1 | 25mg1 |
| Rules around taking it | A weekly injection | Empty stomach, sip of water, wait 30 minutes before eating or drinking1 |
| Injection-site reactions | Possible: redness, swelling, lumps5 | None, because there is no injection |
| Common side effects | Gastrointestinal effects such as nausea, vomiting, diarrhoea and constipation for both1,3 | |
| Skin-specific research | Limited for semaglutide generally, and none specific to the tablet5 | |
The doses look very different on paper, so do not compare the milligram numbers directly. What is telling is that people on the full-dose 2.4mg injection can switch straight to the 25mg tablet, which suggests the two are intended to do the same job.1 The empty-stomach rules exist because food and drink may reduce how much of the tablet is absorbed.1
Changing how a medicine gets into your body changes the routine around it. It does not change what the medicine does once it is there.
03. WHAT WE KNOW ABOUT SEMAGLUTIDE AND SKIN
THE EVIDENCE IS THIN
A 2025 review of the skin effects of GLP-1 medicines states that its authors found no large-scale clinical studies on their dermatological effects.5 Much of what is discussed online comes from case reports, small studies and expert opinion.
FACIAL VOLUME AND "OZEMPIC FACE"
The same review describes significant facial volume loss when rapid fat reduction depletes the fat under the skin, with collagen and elasticity changes possibly contributing. It says the exact mechanism is unclear and the term "Ozempic face" lacks medical validation.5 A separate 2025 review of changes around the eyes describes hollowing as an effect of rapid weight loss rather than a confirmed direct effect of the drug.6
HAIR
The 2025 review notes that GLP-1 medicines could cause hair thinning or shedding, possibly because of rapid weight loss and nutritional shortfalls, or a direct effect on hair follicles, and says this needs more research.5 I have not been able to find published hair-loss figures for the tablet that I could check, so I am not going to quote any. Your patient information leaflet lists the side effects reported in trials, and your pharmacist can talk you through them.
STRETCH MARKS AND LOOSE SKIN
The NHS lists losing or gaining weight quickly as one of the causes of stretch marks.7 That applies to any route to fast weight loss, tablet, injection or otherwise.
What this means in practice.
If the tablet leads to similar weight loss at a similar pace, expect similar skin changes. If you lose weight more slowly on it, for any reason, that may be easier on your skin. Neither has been studied directly.
04. SAFETY STILL COMES FIRST
- Eyes: the MHRA says semaglutide, including the Rybelsus tablet, is linked very rarely, in up to 1 in 10,000 people, to a serious eye condition called NAION. Sudden loss of vision, or eyesight that worsens very quickly, needs eye casualty or A&E urgently.4
- Pregnancy: the MHRA advises avoiding pregnancy while taking GLP-1 medicines, stopping semaglutide at least two months before trying to conceive, and not using them while breastfeeding.3
- Buying it: only with a prescription after a consultation, from a registered pharmacy. Not from social media, salons or unregulated sellers.3
- Side effects: report suspected side effects to your prescriber and through the MHRA Yellow Card scheme.1
Whether to take the tablet, the injection or neither, and at what dose, is a decision for you and your prescriber. Nothing here is a reason to switch or stop.
05. LOOKING AFTER YOUR SKIN ON EITHER FORM
I am going to be blunt, because this category is full of overpromising. No skincare can stop skin changing while you lose weight, and none removes excess skin. What a consistent routine does is keep skin hydrated, comfortable and better-looking while your body changes. That is the same whether your semaglutide comes in a pen or a blister pack.
One practical note for tablet users: you will be up, fasting and waiting 30 minutes each morning. That is a good window for your morning skincare.
HYDRATION CONTINUUM GEL
Hyaluronic acid with sodium PCA and aloe. Straight after your morning shower on the face, neck, décolletage and arms.
On the tablet you wait 30 minutes each morning before eating or drinking,1 and a gel straight after the shower fits neatly into that window. Hyaluronic acid was chosen because, in a randomised trial of a different product, hyaluronic acid creams improved skin hydration compared with a plain cream.8
COLLAGEN ARCHITECT SERUM
Multi-weight hyaluronic acid and sodium PCA to support the look of firmer, more hydrated skin on the face, neck and chest, and the abdomen if that is your focus.
Facial volume loss is linked to rapid weight loss, whichever form you take.5,6 A light morning serum on the face, neck and chest supports the look of firmer, more hydrated skin while things are changing.
REGENESIS COMPLEX
A peptide serum with hexapeptide-11 and dipalmitoyl hydroxyproline for anywhere you are losing weight: stomach, thighs, arms, neck.
Stretch marks are linked to losing weight quickly, by any route.7 Regenesis Complex is made for the body, so your stomach, thighs and arms get the same attention as your face.
EVOLVE SERUM
Bakuchiol with rosehip, evening primrose and jojoba oils, straight after Regenesis Complex, on areas with stretch marks or uneven texture.
It will not remove stretch marks; nothing on the shelf does. It is a nourishing oil that keeps the skin on those areas soft and comfortable while your body changes.
RESILIENCE MATRIX NIGHT CREAM
Shea and cocoa butter with plant glycosphingolipids, as you get into bed, on the face, neck and décolletage.
Rich butters keep skin comfortable overnight. It is one simple last step, and it is the same whether your semaglutide comes in a pen or a blister pack.
In our pre-launch trial of the topical routine, all 11 participants said their skin felt more hydrated after six weeks, and 9 of 11 said it felt more comfortable (see the evidence).
06. FAQ
IS THE WEGOVY PILL THE SAME AS THE INJECTION?
It contains the same active medicine, semaglutide, but is taken daily as a tablet rather than weekly by injection, with strict rules about an empty stomach.1
DOES THE WEGOVY PILL CAUSE LOOSE SKIN OR "OZEMPIC FACE"?
There is no research specific to the tablet. Facial hollowing and looser skin are linked to rapid weight loss, which can happen on either form.5,6
DOES THE WEGOVY PILL CAUSE HAIR LOSS?
Hair thinning has been discussed with GLP-1 medicines, possibly linked to rapid weight loss and nutrition.5 Check your patient leaflet and speak to your pharmacist or GP if you notice shedding.
WHAT ARE THE MAIN SIDE EFFECTS OF THE WEGOVY PILL?
The most common are gastrointestinal, such as nausea, diarrhoea and constipation.1 Report suspected side effects to your prescriber and the Yellow Card scheme.
IS THE WEGOVY PILL AVAILABLE ON THE NHS?
At approval in June 2026 it was not, pending NICE assessment.2 Your GP can tell you the current position.
SHOULD I SWITCH TO THE PILL FOR MY SKIN?
There is no evidence that switching helps your skin. It is a medical decision for you and your prescriber, not a skincare one.
RELATED ARTICLES FROM THE SKIN JOURNAL
SOURCES
All sources checked in October 2026.
-
Robertson J. MHRA approves semaglutide oral tablets for weight loss. The Pharmaceutical Journal, 12 June 2026.
Read the source -
Manufacturing Chemist. MHRA approves first oral semaglutide tablet for weight loss in the UK. Manufacturing Chemist, 11 June 2026.
Read the source -
Medicines and Healthcare products Regulatory Agency (MHRA). GLP-1 medicines for weight loss and diabetes: what you need to know. GOV.UK, published 5 June 2025, updated 5 February 2026.
Read the source on GOV.UK -
Medicines and Healthcare products Regulatory Agency (MHRA). Semaglutide (Wegovy, Ozempic and Rybelsus): risk of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION). Drug Safety Update, 5 February 2026.
Read the source on GOV.UK -
Persson C, Eaton A, Mayrovitz HN. A Closer Look at the Dermatological Profile of GLP-1 Agonists. Diseases, 2025;13(5):127.
Read the source -
Kapantais D, Tsoutsanis P. Functional and Aesthetic Periorbital, Ocular Adnexal and Ocular Surface Changes Linked to GLP-1 Receptor Agonists. Journal of Clinical Medicine, 2025;14(24):8792.
Read the source -
NHS. Stretch marks. NHS website, last reviewed 30 April 2024.
Read the source on NHS.uk -
Pavicic T, Gauglitz GG, Lersch P, et al. Efficacy of Cream-Based Novel Formulations of Hyaluronic Acid of Different Molecular Weights in Anti-Wrinkle Treatment. Journal of Drugs in Dermatology, 2011;10(9):990–1000.
Read the source on PubMed
This article is general information, not medical advice. ElastiK° products are cosmetics and support the appearance of skin; they do not treat medical conditions.






